Personalized Peptide Cancer Vaccine NEO-PV-01

**Semantic type:** Immunologic Factor|Pharmacologic Substance

**Definition:** A synthetic peptide-based, personalized cancer vaccine consisting of patient-specific mutated peptide epitopes, which are immunogenic and unique to the patient's tumor, with potential immunomodulating and antineoplastic activities. Vaccination with the neoantigen-based anti-cancer vaccine NEO-PV-01 stimulates the host immune system to mount a specific and potent cytotoxic T-lymphocyte (CTL) response against tumor cells expressing the neoantigens, which results in tumor cell lysis.

**Synonyms:** - NEO PV 01 - NEO-PV 01 - NEO-PV-01 - Neoantigen-based Anticancer Vaccine NEO-PV-01 - Neoantigen-based Peptide Vaccine NEO-PV-01